Product Information
OXYBUTYNIN 5 MG TABLET is a generic product labeled by TruPharma LLC, priced at $0.0473 per EA under NDC 52817026010. Its NADAC has been published 363 times since Jul 17, 2019.
Strength
5 mg/1
Manufacturer
TruPharma LLCNDC
52817026010
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210125On Market Since
1/1/2019
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN 5 MG TABLET has been published 363 times since Jul 17, 2019, and over the history we have for it it has declined 73.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0473 per EA |
|---|---|
| All-time high | $0.1805 (Aug 14, 2019) |
| All-time low | $0.0448 (Nov 20, 2024) |
| 52-week high | $0.0505 |
| 52-week low | $0.0455 |
| Median price | $0.0701 |
| Average price | $0.0746 |
| Largest weekly change | -28.1% (Apr 17, 2024) |
| Weeks tracked | 363 |
| Tracking since | Jul 17, 2019 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OXYBUTYNIN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN 5 MG TABLET, manufactured by TruPharma LLC, is $0.0473 per EA (NDC 52817026010), effective Jun 24, 2026.
How has the price of OXYBUTYNIN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN 5 MG TABLET has declined 73.8%. It has been tracked across 363 weekly CMS publications since Jul 17, 2019.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN 5 MG TABLET?
Since Jul 17, 2019, the NADAC for OXYBUTYNIN 5 MG TABLET has ranged from a low of $0.0448 (Nov 20, 2024) to a high of $0.1805 (Aug 14, 2019), with a median of $0.0701 per EA.
Are there cheaper alternatives to OXYBUTYNIN 5 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as OXYBUTYNIN 5 MG TABLET, but none are currently priced below it.
Who manufactures OXYBUTYNIN 5 MG TABLET?
OXYBUTYNIN 5 MG TABLET (NDC 52817026010) is labeled by TruPharma LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification